日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan

达格列净在慢性肾脏病中的应用及其在美国和日本低蛋白尿患者中的真实世界疗效

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-023-02773-x
Tangri, Navdeep; Rastogi, Anjay; Nekeman-Nan, Cassandra; Hong, Lai San; Ozaki, Asuka; Franzén, Stefan; Sofue, Tadashi
发表日期：2024
文献求助 收藏

Anifrolumab Study for Treatment Effectiveness in the Real World (ASTER) among patients with systemic lupus erythematosus: protocol for an international observational effectiveness study

阿尼弗鲁单抗治疗系统性红斑狼疮患者真实世界疗效研究（ASTER）：一项国际观察性疗效研究方案

期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2024-086055
Mosca, Marta; Emmas, Cathy; Nekeman-Nan, Cassandra; Stirnadel-Farrant, Heide; Chen, Samuel; Carty, Lucy; Waratani, Miina; Seo, Caroline; Chen, Stephanie; Sorrentino, Alessandro
红斑狼疮
免疫/内分泌
发表日期：2024
文献求助 收藏

The Effect of Including eHealth in Dietary Interventions for Patients with Type 2 Diabetes with Overweight or Obesity: A Systematic Review

将电子健康纳入2型糖尿病合并超重或肥胖患者的饮食干预措施的效果：一项系统评价

期刊:Nutrients
影响因子:5
doi:10.3390/nu15173776
Geurts, Karlijn A M; Woodcock-Nekeman, Sandra; Hummel, Mitchell; Dietvorst, Carmen A W; van Rossum, Elisabeth F C; Berk, Kirsten A
肥胖
代谢
糖尿病
发表日期：2023
文献求助 收藏

The cost-effectiveness of dapagliflozin compared to DPP-4 inhibitors in the treatment of type 2 diabetes mellitus in the Netherlands

在荷兰，达格列净与DPP-4抑制剂治疗2型糖尿病的成本效益比较

期刊:Diabetic Medicine
影响因子:3.4
doi:10.1111/dme.14371
Van der Linden, N; Van Olst, S; Nekeman, S; Uyl-de Groot, C A
代谢
糖尿病
发表日期：2021
文献求助 收藏

Health-related quality of life around the time of diagnosis in patients with bladder cancer

膀胱癌患者确诊前后健康相关生活质量

期刊:Bju International
影响因子:4.4
doi:10.1111/bju.14804
Yu, Evan Yi-Wen; Nekeman, Duncan; Billingham, Lucinda J; James, Nicholas D; Cheng, K K; Bryan, Richard T; Wesselius, Anke; Zeegers, Maurice P
肿瘤
肿瘤免疫
膀胱癌
发表日期：2019
文献求助 收藏

Patients choose certainty over burden in bladder cancer surveillance

在膀胱癌监测方面，患者更倾向于选择确定性而非负担。

期刊:World Journal of Urology
影响因子:2.9
doi:10.1007/s00345-019-02728-4
van Osch, Frits H M; Nekeman, Duncan; Aaronson, Neil K; Billingham, Lucinda J; James, Nicholas D; Cheng, K K; Bryan, Richard T; Zeegers, Maurice P
肿瘤
肿瘤免疫
膀胱癌
发表日期：2019
文献求助 收藏

Fruit and vegetable intake and the risk of recurrence in patients with non-muscle invasive bladder cancer: a prospective cohort study

水果和蔬菜摄入量与非肌层浸润性膀胱癌患者复发风险的关系：一项前瞻性队列研究

期刊:Cancer Causes & Control
影响因子:2.1
doi:10.1007/s10552-018-1029-9
Jochems, Sylvia H J; van Osch, Frits H M; Reulen, Raoul C; van Hensbergen, Mitch; Nekeman, Duncan; Pirrie, Sarah; Wesselius, Anke; van Schooten, Frederik-Jan; James, Nicholas D; Wallace, D Michael A; Bryan, Richard T; Cheng, K K; Zeegers, Maurice P
肿瘤
肿瘤免疫
膀胱癌
发表日期：2018
文献求助 收藏

The association between smoking cessation before and after diagnosis and non-muscle-invasive bladder cancer recurrence: a prospective cohort study

诊断前后戒烟与非肌层浸润性膀胱癌复发之间的关联：一项前瞻性队列研究

期刊:Cancer Causes & Control
影响因子:2.1
doi:10.1007/s10552-018-1046-8
van Osch, Frits H M; Jochems, Sylvia H J; Reulen, Raoul C; Pirrie, Sarah J; Nekeman, Duncan; Wesselius, Anke; James, Nicholas D; Wallace, D Michael A; Cheng, K K; van Schooten, Frederik J; Bryan, Richard T; Zeegers, Maurice P
肿瘤
肿瘤免疫
膀胱癌
发表日期：2018
文献求助 收藏

Total Fluid Intake and the Risk of Recurrence in Patients With Non-Muscle Invasive Bladder Cancer: A Prospective Cohort Study

总液体摄入量与非肌层浸润性膀胱癌患者复发风险：一项前瞻性队列研究

期刊:Bladder Cancer
影响因子:1.2
doi:10.3233/BLC-180172
Jochems, Sylvia H J; van Osch, Frits H M; Reulen, Raoul C; van Hensbergen, Mitch; Nekeman, Duncan; Pirrie, Sarah J; Wesselius, Anke; van Schooten, Frederik J; James, Nicholas D; Wallace, D Michael A; Bryan, Richard T; Cheng, K K; Zeegers, Maurice P
膀胱癌
肿瘤免疫
肿瘤
发表日期：2018
文献求助 收藏